The Valley Desk

NCT03849469 · Interventional trial

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Overall registry status Completed

Phase 1

Conditions Advanced or Metastatic Solid Tumors, Cervical Carcinoma, Colorectal Carcinoma, Endometrial Carcinoma, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Gastric or Gastroesophageal Junction Adenocarcinoma, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Melanoma, Nasopharyngeal Carcinoma, Non-small Cell Lung Carcinoma, Pancreatic Carcinoma, Primary Peritoneal Carcinoma, Prostate Carcinoma, Renal Cell Carcinoma, Small Cell Lung Carcinoma, Squamous Cell Anal Cancer, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Penile Carcinoma, Squamous Cell Vulvar Carcinoma, Triple Negative Breast Cancer, Urothelial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov